Consumer Electronics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Consumer Electronics Industry Thrives on Technological Advancements and Changing Lifestyles
The global consumer electronics market has witnessed substantial growth in recent years, driven by technological innovation and changing consumer preferences. According to the latest market research, as of 2024, the global demand for consumer electronics was valued at a staggering US$ 755 billion and is projected to reach a remarkable US$ 1150 billion by the end of 2031.
A Revolution in Everyday Life
Consumer electronics, encompassing a wide range of devices such as smartphones, tablets, smartwatches, and internet-connected appliances, have become indispensable in our daily lives. They have made tasks easier and more efficient, enabling remote work, entertainment, and improved connectivity. The continued innovation in technology and the growing demand among consumers are the driving forces behind the industry's remarkable growth.
Rising Demand in North America
In 2024, the North American market dominated the global landscape and is expected to maintain its position throughout the forecast period. The United States, in particular, is leading the region, driven by the integration of advanced technologies and the growing demand for innovative devices and electronic components. The fast-paced American lifestyle is increasingly favoring digital existence, with automation for daily tasks becoming a priority.
The Smart Home Revolution
The proliferation of smart homes and the widespread adoption of voice assistants like Google Home, Siri, and Alexa are fueling the demand for audio and video equipment. The integration of consumer electronics with voice assistance equipment is creating new opportunities and enhancing market prospects. Innovations like Google's voice recognition technology improvements and partnerships like Stats Perform with AI specialist Veritone are shaping the future of consumer electronics.
China's Impressive Growth
China, a major producer of electronic components and raw materials, is contributing significantly to the consumer electronics market's supply chain. The Chinese market is witnessing increased adoption of appliances with voice assistance, Bluetooth, and Wi-Fi connectivity, making lives more convenient. With technological advancements and a preference for smart devices, China's consumer electronics market is projected to expand at an impressive CAGR over the next decade.
Opportunities in Europe
Germany and the United Kingdom stand out as opportune regional markets in Europe. The adoption and penetration of consumer electronic devices such as smartphones, televisions, personal computers, and cameras are high in terms of both volume and value. Companies in the consumer electronics industry are actively investing in research and development and collaborating to drive innovation.
Competitive Landscape
Key players in the global consumer electronics market, including,
• Samsung Electronics Co. Ltd.
• LG Electronics Co. Ltd.
• Apple Inc.
• Hitachi Ltd.
• Koninklijke Philips N.V.
• Sony Corporation
• Hewlett-Packard Inc. (HP)
• Toshiba Corporation
• Panasonic Corporation
• Others
are focusing on strategies such as mergers, acquisitions, geographical expansion, and product development to gain a competitive edge in the market.
Key Segments of Consumer Electronics Market Research
By Device Type:
• Wearable Device
• Smart Home Device
By Consumer Electronic Device:
• Smartphone
• Feature Phone
• Tablet
• Smart TV
• Other TV
• Set-top Box
• Personal Computer
• Digital Camcorder & Camera
• Digital Media Adapter
• Game Console
• Printer
• Other Consumer Electronic Device
By Region:
• North America
• Latin America
• Europe
• East Asia
• South Asia & Pacific
• Middle East and Africa (MEA)
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global Rare Endocrine Disease Treatment Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value and Volume, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 3.1. Global Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Acromegaly
- 3.1.1.2. Central Diabetes Insipidus
- 3.1.1.3. Ahumada-Del Castillo Syndrome
- 3.1.1.4. Hypoparathyroidism
- 3.1.1.5. Other Indications
- 3.2. Global Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Biologics
- 3.2.1.2. Organic Compounds
- 3.3. Global Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Injectables
- 3.3.1.2. Oral
- 3.3.1.3. Others
- 3.4. Global Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. Hospital Pharmacies
- 3.4.1.2. Retail Pharmacies
- 3.4.1.3. Online Pharmacies
- 3.5. Global Rare Endocrine Disease Treatment Market Outlook, by Region, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 4.1. North America Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Acromegaly
- 4.1.1.2. Central Diabetes Insipidus
- 4.1.1.3. Ahumada-Del Castillo Syndrome
- 4.1.1.4. Hypoparathyroidism
- 4.1.1.5. Other Indications
- 4.2. North America Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Biologics
- 4.2.1.2. Organic Compounds
- 4.3. North America Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Injectables
- 4.3.1.2. Oral
- 4.3.1.3. Others
- 4.4. North America Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. Hospital Pharmacies
- 4.4.1.2. Retail Pharmacies
- 4.4.1.3. Online Pharmacies
- 4.5. North America Rare Endocrine Disease Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.2. U.S. Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.3. U.S. Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.4. U.S. Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.5. Canada Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.6. Canada Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.7. Canada Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.1.8. Canada Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 5.1. Europe Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Acromegaly
- 5.1.1.2. Central Diabetes Insipidus
- 5.1.1.3. Ahumada-Del Castillo Syndrome
- 5.1.1.4. Hypoparathyroidism
- 5.1.1.5. Other Indications
- 5.2. Europe Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Biologics
- 5.2.1.2. Organic Compounds
- 5.3. Europe Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Injectables
- 5.3.1.2. Oral
- 5.3.1.3. Others
- 5.4. Europe Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Hospital Pharmacies
- 5.4.1.2. Retail Pharmacies
- 5.4.1.3. Online Pharmacies
- 5.5. Europe Rare Endocrine Disease Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. Germany Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.2. Germany Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.3. Germany Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.4. Germany Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.5. U.K. Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.6. U.K. Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.7. U.K. Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.8. U.K. Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.9. France Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.10. France Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.11. France Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.12. France Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.13. Italy Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.14. Italy Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.15. Italy Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.16. Italy Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.17. Turkey Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.18. Turkey Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.19. Turkey Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.20. Turkey Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.21. Russia Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.22. Russia Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.23. Russia Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.24. Russia Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.25. Rest of Europe Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.26. Rest of Europe Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.27. Rest of Europe Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.1.28. Rest of Europe Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 6.1. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Acromegaly
- 6.1.1.2. Central Diabetes Insipidus
- 6.1.1.3. Ahumada-Del Castillo Syndrome
- 6.1.1.4. Hypoparathyroidism
- 6.1.1.5. Other Indications
- 6.2. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Biologics
- 6.2.1.2. Organic Compounds
- 6.3. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Injectables
- 6.3.1.2. Oral
- 6.3.1.3. Others
- 6.4. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Hospital Pharmacies
- 6.4.1.2. Retail Pharmacies
- 6.4.1.3. Online Pharmacies
- 6.5. Asia Pacific Rare Endocrine Disease Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. China Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.2. China Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.3. China Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.4. China Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.5. Japan Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.6. Japan Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.7. Japan Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.8. Japan Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.9. South Korea Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.10. South Korea Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.11. South Korea Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.12. South Korea Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.13. India Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.14. India Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.15. India Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.16. India Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.17. Southeast Asia Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.18. Southeast Asia Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.19. Southeast Asia Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.20. Southeast Asia Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.21. Rest of Asia Pacific Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.22. Rest of Asia Pacific Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.23. Rest of Asia Pacific Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.1.24. Rest of Asia Pacific Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 7.1. Latin America Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Acromegaly
- 7.1.1.2. Central Diabetes Insipidus
- 7.1.1.3. Ahumada-Del Castillo Syndrome
- 7.1.1.4. Hypoparathyroidism
- 7.1.1.5. Other Indications
- 7.2. Latin America Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.2.1. Key Highlights
- 7.2.1.1. Biologics
- 7.2.1.2. Organic Compounds
- 7.3. Latin America Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Injectables
- 7.3.1.2. Oral
- 7.3.1.3. Others
- 7.4. Latin America Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.4.1. Key Highlights
- 7.4.1.1. Hospital Pharmacies
- 7.4.1.2. Retail Pharmacies
- 7.4.1.3. Online Pharmacies
- 7.5. Latin America Rare Endocrine Disease Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.2. Brazil Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.3. Brazil Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.4. Brazil Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.5. Mexico Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.6. Mexico Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.7. Mexico Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.8. Mexico Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.9. Argentina Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.10. Argentina Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.11. Argentina Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.12. Argentina Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.13. Rest of Latin America Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.14. Rest of Latin America Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.15. Rest of Latin America Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.1.16. Rest of Latin America Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Acromegaly
- 8.1.1.2. Central Diabetes Insipidus
- 8.1.1.3. Ahumada-Del Castillo Syndrome
- 8.1.1.4. Hypoparathyroidism
- 8.1.1.5. Other Indications
- 8.2. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Biologics
- 8.2.1.2. Organic Compounds
- 8.3. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Injectables
- 8.3.1.2. Oral
- 8.3.1.3. Others
- 8.4. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Hospital Pharmacies
- 8.4.1.2. Retail Pharmacies
- 8.4.1.3. Online Pharmacies
- 8.5. Middle East & Africa Rare Endocrine Disease Treatment Market Outlook, by Country, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. GCC Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.2. GCC Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.3. GCC Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.4. GCC Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.5. South Africa Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.6. South Africa Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.7. South Africa Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.8. South Africa Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.9. Egypt Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.10. Egypt Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.11. Egypt Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.12. Egypt Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.13. Nigeria Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.14. Nigeria Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.15. Nigeria Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.16. Nigeria Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.17. Rest of Middle East & Africa Rare Endocrine Disease Treatment Market by Distribution Channel, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.18. Rest of Middle East & Africa Rare Endocrine Disease Treatment Market by Drug Type, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.19. Rest of Middle East & Africa Rare Endocrine Disease Treatment Market by Mode of Administration, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.1.20. Rest of Middle East & Africa Rare Endocrine Disease Treatment Market by Indication, Value (US$ Mn) and Volume (Tons), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. by Mode of Administration vs by Drug Type Heatmap
- 9.2. Manufacturer vs by Drug Type Heatmap
- 9.3. Company Market Share Analysis, 2023
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Novartis
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. Ipsen
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. Pfizer, Inc
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. Teva
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. EMD serono
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. Novo Nordisk
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Eli Lilly
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 9.5.8. Shire
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Portfolio
- 9.5.8.3. Financial Overview
- 9.5.8.4. Business Strategies and Development
- 9.5.9. Amgen, Inc
- 9.5.9.1. Company Overview
- 9.5.9.2. Product Portfolio
- 9.5.9.3. Financial Overview
- 9.5.9.4. Business Strategies and Development
- 9.5.10. Corcept Therapeutics
- 9.5.10.1. Company Overview
- 9.5.10.2. Product Portfolio
- 9.5.10.3. Financial Overview
- 9.5.10.4. Business Strategies and Development
- 9.5.11. Novelion Therapeutics
- 9.5.11.1. Company Overview
- 9.5.11.2. Product Portfolio
- 9.5.11.3. Financial Overview
- 9.5.11.4. Business Strategies and Development
- 9.5.12.
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook